XML 58 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (USD $)
Dec. 31, 2012
Dec. 31, 2011
Current Assets    
Cash and cash equivalents $ 13,737,452 $ 3,935,160
Accounts receivable trade, net of allowance for doubtful accounts of $626,054 and $187,600, respectively 1,053,604 1,010,475
Inventory 1,113,025 647,745
Prepaids and other current assets 803,135 649,739
Assets related to discontinued operations 0 32,367,217
Total current assets 16,707,216 38,610,336
Property, plant and equipment, net 11,153,143 11,616,053
Goodwill 11,117,770 11,117,770
Intangible assets, net 14,480,827 15,086,038
Other assets 947,307 3,326,938
Assets related to discontinued operations 0 75,570,645
Assets, Total 54,406,263 155,327,780
Current Liabilities    
Accounts payable 2,555,240 2,287,201
Accrued liabilities 2,284,813 1,090,176
Notes payable 202,558 148,062
Mortgages payable 3,438,475 3,635,061
Unearned revenues 1,468,341 1,121,134
Liabilities related to discontinued operations 0 28,165,010
Total current liabilities 9,949,427 36,446,644
Long-term Liabilities    
Deferred income taxes 3,599,122 3,774,655
Unearned revenues 0 169,198
Notes payable 171,528 0
Derivative liabilities 101,156 474,463
Acquisition-related contingent consideration 7,550,000 3,130,000
Other long-term liabilities 214,871 0
Liabilities related to discontinued operations 0 26,388,976
Total long-term liabilities 11,636,677 33,937,292
Commitments and Contingencies      
Redeemable Securities    
Convertible Redeemable Series E Preferred Stock; 10,582,011 shares designated, liquidation value $1.00 per share; issued and outstanding 0 shares and 6,662,748 shares at December 31, 2012 and 2011, respectively 0 4,811,326
Stockholders' Equity    
Preferred stock; authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 1 share of common stock, $.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at December 31, 2012 and December 31, 2011 100 100
Common stock, $.001 par value, authorized 500,000,000 shares; issued and outstanding, 163,753,653 and 109,329,587 shares, at December 31, 2012 and December 31, 2011, respectively 163,754 109,330
Additional paid-in capital 231,071,236 200,858,638
Treasury stock, at cost (665,600) 0
Accumulated deficit (197,392,361) (143,094,854)
Accumulated other comprehensive income 0 4,152,343
Total NeoStem, Inc. stockholders' equity 33,177,129 62,025,557
Noncontrolling interests (356,970) 18,106,961
Total equity 32,820,159 80,132,518
Liabilities and Equity, Total $ 54,406,263 $ 155,327,780